Life Sciences IPOs Take a Breather December 02, 2013 | Press Release

Booming IPO Market Improving M&A Terms for Private Biotechs November 01, 2013 | Press Release

ADMA Biologics, Inc. Announces Pricing October 18, 2013 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.

Merchant Banking

Since its foundation, Burrill has built worldwide capabilities unmatched by other boutique Life Sciences banking firms, including:

• A multicultural, multilingual team spanning the globe
• Extensive international business relationships
• Worldwide pharmaceutical regulatory and marketing experience

These capabilities are particularly important in this ever-shrinking world, as the dynamics of technologies, end-markets and capital increasing operate on a global scale.

Ways Burrill can bring its international capabilities to bear include:

• Capital Access - Assisting companies worldwide in accessing the attractive and dominant United States investment market
• Technology Access - Cross-border buyside and sellside activities for companies looking to expand their technology portfolio
• Market Access - In-licensing and out-licensing projects to take advantage of emerging global markets